Author

M. Boissinot

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Droit· 1 shared A. P. Droop· 1 shared B. da Silva· 1 shared C. Dauly· 1 shared C. Gotti· 1 shared D. C. Tomlinson· 1 shared D. Tams· 1 shared E. E. Morrison· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Droit

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A high-content screen profiles cytotoxic microRNAs in pediatric and adult glioblastoma cells and identifies miR-1300 as a potent inducer of cytokinesis failure

M. Boissinot, H. King, M. Adams, J. Higgins, T. A. Ward, L. P. Steele, D. Tams, R. Morton, E. Polson, B. da Silva, A. P. Droop, J. L. Hayes, H. Martin, P. Laslo, E. E. Morrison, , S. C. Short

This study identifies miR-1300 as a potent cytotoxic microRNA in glioblastoma cells, causing cytokinesis failure and apoptosis, with potential therapeutic applications.

bioRxiv · Oct 1, 2019 · PreprintCancer Biology

Fast and accurate bacterial species identification in biological samples using LC-MS/MS mass spectrometry and machine learning

F. Roux-Dalvai, C. Gotti, M. Leclercq, M.-C. Helie, M. Boissinot, T. N. Arrey, C. Dauly, F. Fournier, I. Kelly, J. Marcoux, J. Bestman-Smith, M. G. Bergeron, A. Droit

This paper develops a method using LC-MS/MS and machine learning to rapidly identify bacterial species in clinical samples without culture, achieving 97% accuracy for UTI pathogens.

bioRxiv · May 10, 2019Microbiology